Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.

about

Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.

Item

http://www.wikidata.org/entity/Q42499130

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@en

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@nl

type

Item

label

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@en

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@nl

prefLabel

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@en

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@nl

P1476

Progenitor cell secretory prod ...... nhibitors in experimental CKD.

@en

P2093

Darren A Yuen

http://www.w3.org/2001/XMLSchema#string

David M Kepecs

http://www.w3.org/2001/XMLSchema#string

Kerri Thai

http://www.w3.org/2001/XMLSchema#string

Kim A Connelly

http://www.w3.org/2001/XMLSchema#string

Richard E Gilbert

http://www.w3.org/2001/XMLSchema#string

Yanling Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

Supramaximal dose of candesartan in proteinuric renal disease

Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Isolation of putative progenitor endothelial cells for angiogenesis

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Paracrine mechanisms in adult stem cell signaling and therapy

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

P31

scholarly article

P356

10.1177/1470320316668434

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27638853

http://www.w3.org/2001/XMLSchema#string

P932

5843926

http://www.w3.org/2001/XMLSchema#string